Last $22.44 USD
Change Today +0.28 / 1.26%
Volume 404.6K
MASI On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 8:10 PM 08/29/14 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

40 Parker

Irvine, CA 92618

United States

Phone: 949-297-7000

Fax: 949-297-7499

Masimo Corporation, a global medical technology company, develops, manufactures, and markets noninvasive patient monitoring products. The company’s Masimo Signal Extraction Technology (Masimo SET) allows pulse oximeters to provide accurate measurements even during patient motion and low perfusion conditions. The company’s main business is measure through motion and low perfusion arterial blood oxygen saturation and pulse rate monitoring, known as Masimo SET pulse oximetry. Its product offerings also include noninvasive blood constituent, brain and breath monitoring, including rainbow Pulse CO-Oximetry, brain function electroencephalogram (EEG) monitoring, respiration rate, capnography and anesthetic agent monitoring. In addition, the company has developed the Root patient monitoring and connectivity platform and Patient SafetyNet remote patient surveillance monitoring system. The company provides its products directly and through distributors and original equipment manufacturer (OEM) partners to hospitals, emergency medical service (EMS) providers, physician offices, veterinarians, long term care facilities and consumers. The company licensed from Cercacor Laboratories, Inc. (Cercacor), the right to OEM selected rainbow technology to incorporate selected rainbow technology into its products intended to be used by professional caregivers, including hospital caregivers and alternate care facility caregivers. Circuit Boards Masimo SET MS Circuit Boards: The company’s Masimo SET MS circuit boards perform signal processing and other pulse oximetry functions incorporating the Masimo SET platform. The company’s MS circuit boards are included in its proprietary monitors for direct sale or sold to its OEM partners for incorporation into their monitors. Once incorporated into a pulse oximeter, the MS circuit boards perform data acquisition processing and report the pulse oximetry levels to the host monitor. The circuit boards and related software interface directly with its proprietary sensors to calculate arterial blood oxygen saturation level and pulse rate. The company’s new generation boards include the MS-2003, MS-2011, MS-2013, and the new MS-2040, with a typical power consumption of less than 45 milliwatts. Masimo rainbow SET MX Circuit Boards: The company’s next-generation circuit board is the foundation for its Masimo rainbow Pulse CO-Oximetry and rainbow Acoustic Monitoring platform, utilizing technology licensed from Cercacor. The MX circuit boards measure arterial blood oxygen saturation levels and pulse rate, and have the circuitry to enable the measurement of hemoglobin, oxygen content, carboxyhemoglobin, methemoglobin, Pleth Variability Index (PVI), respiration rate and halo index, along with other potential measurements in the future. uSpO2 Cable/Board: The company’s new SET technology-in-a-cable contains the low power (MS-2040) technology in a reduced size, allowing it to be embedded into patient cables as part of the sensor connector. This allows for the ability to interface the uSpO2 cable/board to monitoring devices externally via an existing communications port in instances where internal integration of a traditional Masimo SET technology board is not feasible. The uSpO2 cable/board provides full Masimo SET Measure-Through Motion and Low Perfusion pulse oximetry found in its other products, with a typical power consumption of less than 45 milliwatts. Monitors/Devices Radical-7: The company’s Radical-7 incorporates the MX circuit board, which enables rainbow SET measurements, and offers three-in-one capability to be used as a standalone device for bedside monitoring; a detachable, battery-operated handheld unit for portable monitoring; and a monitor interface via SatShare, a proprietary technology allowing its products to work with certain competitor products, to upgrade existing conventional multi-parameter patient monitors to Masimo SET while displaying rainbow measurements on the Radical-7 itself. SatShare: SatShare technology enables a conventional monitor to upgrade to Masimo SET through a cable connection from the back of Radical-7 to the sensor input port of the conventional

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MASI:US $22.44 USD +0.28

MASI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CAS Medical Systems Inc $1.59 USD +0.05
CONMED Corp $39.50 USD +0.36
Hutchinson Technology Inc $4.49 USD -0.21
Integra LifeSciences Holdings Corp $49.99 USD +0.33
LiDCO Group PLC 14.50 GBp -0.25
View Industry Companies
 

Industry Analysis

MASI

Industry Average

Valuation MASI Industry Range
Price/Earnings 21.0x
Price/Sales 2.3x
Price/Book 3.8x
Price/Cash Flow 20.0x
TEV/Sales 1.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MASIMO CORPORATION, please visit www.masimo.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.